Everything you need in a CDMO partner.
Passion. Innovation. Life.
Join us at CPHI
Trusted and affordable medicines, delivered globally.
Enzene appoints new site lead for flagship US continuous biomanufacturing facility
How do Enzene’s CDMO solutions offer a more sustainable, cost-effective path to market?
What can the world’s only fully-connected continuous manufacturing platform do for you?
Problems we solve
With years of technical expertise and a platform that pushes your projects further, your progress is our priority.
Portfolio and licensing
Exclusive biosimilar licensing opportunities and AAV kits for gene therapy applications.
Who is Enzene?
We are a global CDMO dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
Committed to innovation, we have revolutionized biologics production with our patented and validated continuous bioprocess manufacturing platform, EnzeneX™, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars are designed to cater to your project’s every need.
Optimizing manufacturing of a complex bispecific antibody
An emerging biotech approached Enzene Biosciences with a novel Fully Human Albumin Binding (FHAB) protein, which suffered from low titers, poor viability after 10 days of growth, proteolytic clipping, limited operational pH range, and host cell protein (HCP) problems. Find out how we helped them achieve success.
Join the revolution
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.
